Tesamorelin 2 mg (2 vials)

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to increase natural growth hormone production. It is primarily used in medical settings for reducing excess abdominal (visceral) fat, particularly in HIV-associated lipodystrophy, and is also studied for its effects on body composition and metabolic health.

How It Works

Tesamorelin binds to GHRH receptors in the pituitary gland, triggering the release of growth hormone. This increase in GH subsequently raises insulin-like growth factor 1 (IGF-1) levels, supporting fat metabolism, tissue repair, and overall cellular regeneration. Its mechanism helps improve body composition by promoting lipolysis while preserving lean tissue.

Dosage Overview

Tesamorelin is typically administered via subcutaneous injection, with a common dose of 2 mg once daily. It is often injected into abdominal subcutaneous tissue, with injection sites rotated to reduce irritation. Reconstitution with sterile bacteriostatic water is required before use, and proper handling and storage are important for stability. Use should ideally be guided by a healthcare professional.

Potential Benefits

Tesamorelin is associated with reduction of visceral fat, improved body composition, enhanced muscle tone, and better metabolic function. It may also support recovery, energy levels, skin quality, and in some cases cognitive function, making it relevant in both clinical and wellness contexts.

Side Effects and Considerations

Possible side effects include injection site reactions, muscle or joint pain, nausea, fatigue, and in some cases elevated blood glucose levels. Rare hypersensitivity reactions may occur. Due to its hormonal effects, monitoring is recommended during extended use to ensure safety and hormonal balance.